ClinicalTrials.gg
Not yet recruitingNCT04788693GAITimageryUpdated Oct 15, 2024

Effects of Gait Rehabilitation With Motor Imagery in People With Parkinson's Disease

An interventional study of Physical rehabilitation of gait with motor imagery and Physical rehabilitation of gait without motor imagery in Parkinson Disease, sponsored by University of Valencia. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-15.

Sponsored by University of Valencia · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
74
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 225 studies in Parkinson Disease with a site in Spain — 37 open to participants now, 56 under way, 3 of them phase 3. Parkinson Disease · Spain.

Planned enrollment
104th of 179
74 · median 100
Started
2025
with 11 others
No phase
68 of 225
13 open now
Primary completion
2026-12
later than 29 of 55 live
Registered
145th of 225
by date
Lead sponsor
7 of 225
University of Valencia

Among the 225 studies in Parkinson Disease with a site in Spain, this one is the 104th largest by planned enrollment of the 179 interventional ones that give a count, is one of 12 that started in 2025, is one of 68 with no phase, reaches primary completion later than 29 of the 55 other live ones, and was the 145th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

37 of the 225 studies in Parkinson Disease with a site in Spain are open now. Recruiting first, the newest first:

32 more — sign in →

All 37 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 225 studies in Parkinson Disease with a site in Spain, or all of them as a file.
02

Study summary

This study aims to determine whether gait physiotherapy combined with motor imagery exercises has a superior effect than gait physiotherapy without motor imagery in people with Parkinson's disease. To do this, a six-week training program will be carried out twice a week, where walking exercises and motor imaging will be performed in the experimental group while walking exercises only, will be conducted in the control group. Motor imagery exercises consist of developing a mental exercise by which an individual rehearses or simulates a given action. We hypothesize that participants who perform motor imagery exercises have better results than participants who train without imagery exercises. To analyze the effect of the programs will be assess the gait, the functionality in activities of daily living, the motor capacity, and the perception of the quality of life of the participants.

Read the detailed description

Background:

Motor imagery (MI) is a novel technique in neurorehabilitation. Current evidence supports the ability of people diagnosed with Parkinson's disease (PD) to carry out this technique. However, the trials that assess its effectiveness in this pathology are scarce. In some physical rehabilitation programs, MI is introduced to conventional treatment or, MI can be combined with observation of images or neurofeedback. At present, the effect of this technique has been studied in highly heterogeneous variables, including both motor and cognitive abilities or performance of activities of daily living. The evidence seems to indicate that the introduction of MI to conventional treatment, with an adequate dose, may induce greater benefits over people with PD in early stages (I-III on the Hoehn and Yahr scale), especially in daily actions and movements functional such as gait, regardless of medication. However, the small sample size of the trials and the use of non-validated scales and non-objective tests, make it necessary that the results be viewed with caution. On the other hand, the cost-benefit ratio of the therapy, its benefits and its easy application are significant factors to take into account when adding MI to physiotherapy treatment in people with PD.

General objective: To determine whether gait training combined with MI exercises has a superior effect on gait, functionality in activities of daily living, motor capacity, and the perception of the quality of life in people with PD, which gait training without MI.

Specific objectives:

  1. To study the validity of the instrumental technique available for the evaluation of gait and the intra- and inter-rater reliability with the same tool in healthy subjects.
  2. To check the effect, in the short and medium-term, of a gait training program combined with MI in people diagnosed with PD.
  3. To compare the effects of the gait and MI training program with the effects obtained through a gait rehabilitation program without MI exercises.
  4. To contrast the gait pattern of people with PD before and after undergoing a rehabilitation program with MI, with that of healthy older people of the same age, sex, and height.
  5. To observe the differences in the biomechanics of gait between the hemibody most affected by the signs of PD and the hemibody with less clinical alteration, before and after performing a gait training program combined with MI exercises.

Materials and Method:

The evaluation session will be carried out three times: before the treatment, at the end of the intervention, and 8-weeks after the intervention has finished. In each evaluation session, a clinical and biomechanical measurement will be carried out. The biomechanical evaluation will be done using 7 inertial sensors in a 10-meter walk corridor. The inertial sensor or inertial measurement unit (IMU) is made up of three different sensors: gyroscope, accelerometer, and magnetometer, capable of collecting information on the turns, linear acceleration, and magnetic north with respect to the earth's magnetic field. The part of the clinical evaluation includes the assessment of the functionality in the activities of daily living, the motor capacity, and the perception of the quality of life through different questionnaires and assessment scales.

Intervention:

Both, the experimental and control groups of this study, will perform an identical gait physiotherapy program, however, motor imagery exercises will be included in the experimental group.

The gait exercises are aimed at improving specific gait characteristics, so they will include:

  • Exercises for length stride: walk with visual cues on the ground to reach a certain stride length, walk with horizontal poles at a height of 2 cm, walk over steps, treadmill walk.
  • Exercises for Cadence training using a metronome.
  • Exercises for gait velocity training by combining the visual and auditory feedback provided in previous exercises and on the treadmill
  • Exercises for kinematic milestones during the stance and oscillation phase of gait through the mobility of the ankle, knee, and hip joints.

The motor imagery exercises will be performed in supine position on a stretcher, before each gait exercise. The instructions will be administered through the physiotherapy voice. The participant with closed eyes imagines himself performing the gait task while the general guidelines that guide the cognitive process are given. The instructions describe how the person is from the starting position and the different body movements that he must pay attention to during the imagining process. Through the instructions, the participant creates an image of himself and perceives the kinesthesia while performing the exercise. The duration of each motor imagery exercise is 8 minutes.

03

Conditions studied

  • Parkinson Disease

Browse trials for

Keywords

  • Gait rehabilitation
  • Motor imagery
  • Biomechanics of gait
  • Parkinson's disease
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

The inclusion criteria are:

  1. Diagnosed with PD according to the United Kingdom Parkinson's Disease Society Brain Bank diagnostic scale
  2. Independent walk in a 10-meter corridor
  3. Normal cognitive state, determined by the with a score >25
  4. Stable medication from the month before the start of the study until the t2 assessment.

Likewise, the exclusion criteria are:

  1. Additional neurological condition different from PD
  2. Disease or musculoskeletal acute alteration that limits mobility or balance
  3. Lower extremities asymmetries >1 cm
  4. Report pain on the Visual Analog Scale
  5. Suffer from blindness, deafness, or any other visual/hearing impairment or pathology that may influence the ability to understand instructions and carry them out
  6. Significant tremor that may interrupt the MI exercise
  7. To perform other physical therapies or sports during the trial or the two months before.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
74 participants (estimated)

Study arms

  • Experimental
    Motor imagery and gait training group

    Gait training twice a week for six weeks. Each rehabilitation session is composed of an initial 5 minutes of warm-up exercises (general mobility, coordination, strength, flexibility, balance, and breathing), followed by 45 minutes of gait training with motor imagery exercises and a final 10 minutes of muscle stretching. In the central 45 minutes of the session, exercises will be developed to improve objective characteristics of the gait-related to spatiotemporal and kinematic parameters. Objective and subjective feedback will be used for each exercise (cues). In an interspersed way, motor imagery exercises will be carried out where participants must rehearse or simulate mentally each gait exercise that will be developed in the session.

    Other: Physical rehabilitation of gait with motor imagery

  • Active comparator
    Gait training group without motor imagery

    Gait training twice a week for six weeks. Each rehabilitation session is composed of an initial 5 minutes of warm-up exercises (general mobility, coordination, strength, flexibility, balance, and breathing), followed by 45 minutes of gait training with motor imagery exercises and a final 10 minutes of muscle stretching. In the central 45 minutes of the session, exercises will be developed to improve objective characteristics of the gait-related to spatiotemporal and kinematic parameters. Objective and subjective feedback will be used for each exercise (cues). In the periods that the experimental group performs the motor imagery exercises, the control group will take breaks.

    Other: Physical rehabilitation of gait without motor imagery

Interventions

  • OtherPhysical rehabilitation of gait with motor imagery

    Physical rehabilitation of gait is a type of non-invasive treatment that seeks to change the way of performing a task or motor function (in this case, gait) through movement modification and corrected repeated practice, taking into account the alterations, limitations and considerations related to the disease suffered by the person. In this intervention, in addition to physical exercise to correct gait, mental exercises will be included in which the patient visualizes himself performing the exercises that he will then develop with the body.

    Also known as: GAITimagery program

  • OtherPhysical rehabilitation of gait without motor imagery

    Physical rehabilitation of gait is a type of non-invasive treatment that seeks to change the way of performing a task or motor function (in this case, gait) through movement modification and corrected repeated practice, taking into account the alterations, limitations and considerations related to the disease suffered by the person. Motor imagery exercises are not included in this program.

    Also known as: Gait physiotherapy program

06

What researchers measure

Primary outcomes

  1. Gait velocity at the post-training time (primary time point)

    Distance traveled by the body per unit of time at self-selected or comfortable speed, in the direction considered. It is expressed in meters per second (m / s).

    Time frame: 6 weeks

Secondary outcomes

  1. Gait speed variability

    It is calculated through the coefficient of variation (\[standard deviation/mean\] × 100) of gait velocity. Indicates how stable or repeatable the participants are when walking.

    Time frame: 6 weeks

  2. Maximum gait speed

    Distance traveled by the body per unit of time at the maximum possible speed, in the direction considered. It is expressed in meters per second (m/s).

    Time frame: 6 weeks

  3. Stance time

    Time elapsed while the support or stance phase of the gait cycle is developed. It is expressed as a percentage of the total walking cycle and additionally in seconds.

    Time frame: 6 weeks

  4. Weight-acceptance Ground Reaction Force (Newton, N; Weight%)

    Kinetic outcome; First force peak of vertical vector of the ground reaction forces during the stance phase of the gait cycle, which corresponds to the maximum reception of weight on the foot that initiates the gait cycle.

    Time frame: 6 weeks

  5. Midstance Ground Reaction Force (Newton, N; Weight%)

    Kinetic outcome; Lowest force point of the valley located between both maximum force peaks of the vertical vector of the ground reaction forces, which corresponds to the swing of the opposite leg during the gait cycle.

    Time frame: 6 weeks

  6. Push-off Ground Reaction Force (Newton, N; Weight%)

    Kinetic outcome; Second and last force peak of the vertical vector of the ground reaction forces during the stance phase of the gait cycle, which corresponds to the beginning of takeoff of the foot during the last part of the stance phase.

    Time frame: 6 weeks

  7. Breaking Ground Reaction Force (Newton, N; Weight%)

    Kinetic outcome; First maximum force peak of the antero-posterior vector of the ground reaction forces during the gait cycle that corresponds to the braking of the foot on the ground.

    Time frame: 6 weeks

  8. Propulsion Ground Reaction Force (Newton, N; Weight%)

    Kinetic outcome; Second maximum force peak of the antero-posterior vector of the ground reaction forces during the gait cycle that corresponds to the propulsion of the foot on the ground at the end of the stance phase.

    Time frame: 6 weeks

  9. Cadence (steps/min)

    Number of steps executed in a time interval, its most commonly adopted unit being the step per minute.

    Time frame: 6 weeks

  10. Stride length

    Distance measured between two consecutive supports points of the same foot; the heel strike is the reference used. It is expressed in meters (m).

    Time frame: 6 weeks

  11. Step length

    The distance measured between one foot's heel contact and the other's heel contact. It is expressed in meters (m).

    Time frame: 6 weeks

  12. Swing time

    Time elapsed while the swing phase develops. It is expressed as a percentage according to the entire walking cycle and additionally in seconds.

    Time frame: 6 weeks

  13. Double support time

    Time that both feet are in contact with the ground during the gait cycle. It is expressed in seconds (s) and also as a percentage (%) of the total gait cycle.

    Time frame: 6 weeks

  14. Range of motion of lower limb joint (°)

    Kinematic outcome that represents the range of motion in the sagittal plane of the hip, knee, and ankle joints performed during the gait cycle. These parameters will be specified for each limb (right and left).

    Time frame: 6 weeks

  15. Maximum ankle dorsiflexion during swing (°)

    Kinematic outcome; Maximum ankle dorsiflexion angle reached during the swing phase, expressed in degrees.

    Time frame: 6 weeks

  16. Maximum knee flexion during swing (°)

    Kinematic outcome; Maximum knee flexion angle reached during the swing phase, expressed in degrees.

    Time frame: 6 weeks

  17. Maximum hip extension during stance (°)

    Kinematic outcome; Maximum hip extension angle reached during the stance phase, expressed in degrees.

    Time frame: 6 weeks

  18. Maximum hip flexion during swing (°)

    Kinematic outcome; Maximum hip flexion angle reached during the swing phase, expressed in degrees.

    Time frame: 6 weeks

  19. Activities of daily life

    Self-referred Quality of Life measured with the Schwab \& England scale score.

    Time frame: 6 weeks

  20. Quality of Life perceived

    Self-referred quality of life measured with the Parkinson's Disease Questionnaire-39 score questionnaire.

    Time frame: 6 weeks

  21. Freezing of gait

    Freezing of gait Questionnaire score

    Time frame: 6 weeks

  22. Gait qualitative performance with TMT

    Tinetti mobility test - Gait section score

    Time frame: 6 weeks

  23. Gait qualitative performance with DYPAGS

    Dynamic Parkinson Gait Scale score

    Time frame: 6 weeks

  24. Balance qualitative performance with the TMT

    Tinetti mobility test - Balance section score

    Time frame: 6 weeks

  25. Balance qualitative performance with the MiniBest

    MiniBest test score

    Time frame: 6 weeks

  26. Mobility

    Time taken to perform Timed-up and go test (s)

    Time frame: 6 weeks

07

Study locations

1 site
08

References and documents

Publications

  • Leocadi M, Canu E, Sarasso E, Gardoni A, Basaia S, Calderaro D, Castelnovo V, Volonte MA, Filippi M, Agosta F. Dual-task gait training improves cognition and resting-state functional connectivity in Parkinson's disease with postural instability and gait disorders. J Neurol. 2024 Apr;271(4):2031-2041. doi: 10.1007/s00415-023-12151-w. Epub 2024 Jan 8. PubMed 38189921 ↗
  • Sarasso E, Gardoni A, Zenere L, Canu E, Basaia S, Pelosin E, Volonte MA, Filippi M, Agosta F. Action observation and motor imagery improve motor imagery abilities in patients with Parkinson's disease - A functional MRI study. Parkinsonism Relat Disord. 2023 Nov;116:105858. doi: 10.1016/j.parkreldis.2023.105858. Epub 2023 Sep 22. PubMed 37774517 ↗
  • Sarasso E, Agosta F, Piramide N, Gardoni A, Canu E, Leocadi M, Castelnovo V, Basaia S, Tettamanti A, Volonte MA, Filippi M. Action Observation and Motor Imagery Improve Dual Task in Parkinson's Disease: A Clinical/fMRI Study. Mov Disord. 2021 Nov;36(11):2569-2582. doi: 10.1002/mds.28717. Epub 2021 Jul 19. PubMed 34286884 ↗
  • Kashif M, Ahmad A, Bandpei MAM, Gilani SA, Hanif A, Iram H. Combined effects of virtual reality techniques and motor imagery on balance, motor function and activities of daily living in patients with Parkinson's disease: a randomized controlled trial. BMC Geriatr. 2022 Apr 30;22(1):381. doi: 10.1186/s12877-022-03035-1. PubMed 35488213 ↗
  • Kashif M, Ahmad A, Bandpei MAM, Gillani SA, Hanif A, Iram H. Effects of Virtual Reality with Motor Imagery Techniques in Patients with Parkinson's Disease: Study Protocol for a Randomized Controlled Trial. Neurodegener Dis. 2020;20(2-3):90-96. doi: 10.1159/000511916. Epub 2020 Dec 17. PubMed 33333508 ↗
  • Tinaz S, Kamel S, Aravala SS, Elfil M, Bayoumi A, Patel A, Scheinost D, Sinha R, Hampson M. Neurofeedback-guided kinesthetic motor imagery training in Parkinson's disease: Randomized trial. Neuroimage Clin. 2022;34:102980. doi: 10.1016/j.nicl.2022.102980. Epub 2022 Mar 2. PubMed 35247729 ↗
  • Santiago LM, de Oliveira DA, de Macedo Ferreira LG, de Brito Pinto HY, Spaniol AP, de Lucena Trigueiro LC, Ribeiro TS, de Sousa AV, Piemonte ME, Lindquist AR. Immediate effects of adding mental practice to physical practice on the gait of individuals with Parkinson's disease: Randomized clinical trial. NeuroRehabilitation. 2015;37(2):263-71. doi: 10.3233/NRE-151259. PubMed 26484518 ↗
  • Scarpina F, Magnani FG, Tagini S, Priano L, Mauro A, Sedda A. Mental representation of the body in action in Parkinson's disease. Exp Brain Res. 2019 Oct;237(10):2505-2521. doi: 10.1007/s00221-019-05608-w. Epub 2019 Jul 20. PubMed 31327026 ↗
  • Braun S, Beurskens A, Kleynen M, Schols J, Wade D. Rehabilitation with mental practice has similar effects on mobility as rehabilitation with relaxation in people with Parkinson's disease: a multicentre randomised trial. J Physiother. 2011;57(1):27-34. doi: 10.1016/S1836-9553(11)70004-2. PubMed 21402327 ↗
  • Bek J, Webb J, Gowen E, Vogt S, Crawford TJ, Sullivan MS, Poliakoff E. Patients' Views on a Combined Action Observation and Motor Imagery Intervention for Parkinson's Disease. Parkinsons Dis. 2016;2016:7047910. doi: 10.1155/2016/7047910. Epub 2016 Sep 29. PubMed 27777809 ↗
  • Bek J, Gowen E, Vogt S, Crawford TJ, Poliakoff E. Combined action observation and motor imagery influences hand movement amplitude in Parkinson's disease. Parkinsonism Relat Disord. 2019 Apr;61:126-131. doi: 10.1016/j.parkreldis.2018.11.001. Epub 2018 Nov 9. No abstract available. PubMed 30470657 ↗
  • Subramanian L, Morris MB, Brosnan M, Turner DL, Morris HR, Linden DE. Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson's Disease: Randomized Trial. Front Behav Neurosci. 2016 Jun 8;10:111. doi: 10.3389/fnbeh.2016.00111. eCollection 2016. PubMed 27375451 ↗
  • Bezerra PT, Santiago LM, Silva IA, Souza AA, Pegado CL, Damascena CM, Ribeiro TS, Lindquist AR. Action observation and motor imagery have no effect on balance and freezing of gait in Parkinson's disease: a randomized controlled trial. Eur J Phys Rehabil Med. 2022 Oct;58(5):715-722. doi: 10.23736/S1973-9087.22.07313-0. Epub 2022 Sep 1. PubMed 36052889 ↗
  • Tamir R, Dickstein R, Huberman M. Integration of motor imagery and physical practice in group treatment applied to subjects with Parkinson's disease. Neurorehabil Neural Repair. 2007 Jan-Feb;21(1):68-75. doi: 10.1177/1545968306292608. PubMed 17172556 ↗

Individual participant data

Plan to share: No — All measured and recorded data will be shared through the publications made and through their supplementary material.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2025; primary completion for Dec 2026, 15 months later.

Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 15 months is below that.

Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 1, 2021
First posted
Mar 9, 2021
StartEst.
Sep 2025
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Oct 15, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04788693
Collaborators
Asociación Parkinson Valencia
Responsible party
Constanza San Martín (Associate Lecturer professor at the Department of Physiotherapy, University of Valencia) — Principal investigator
First posted
Mar 9, 2021
Start date
Sep 2025 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Oct 15, 2024

Study contacts

Constanza San Martín, PhD.
Contact
constanza.martin@uv.es
963864768
Luz Sánchez, PhD.
Contact
M.Luz.Sanchez@uv.es
963983853
Constanza San Martín, PhD.
principal investigator · Associate Lecturer professor at the Department of Physiotherapy

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion